Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine, neostigmine, and ketamine with epidural bupivacaine for post-laminectomy fibrosis
IRCT20181212041947N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of dexmedetomidine, neostigmine, ketamine and bupivacaine in epidural fibrosis and post-laminectomy syndrome (PLS) (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Mean pain score and Thickness of fibrosis on MRI. Started Aug 2020; status: completed.
02
Drugs
dexmedetomidineneostigmineketaminebupivacaine
03
Conditions
epidural fibrosispost-laminectomy syndrome (PLS)
Beyond the preview
Go deeper on IRCT20181212041947N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181212041947N1.